International conferences and seminars
31.01.2013
11th Cytokines and Inflammation
Dear Colleague,GTC's 11th Cytokines and Inflammation Conference, one of four parallel tracks of the Novel Immunotherapeutics Summit on January 31 - February 1, 2013 in San Diego, CA, promotes a dynamic exchange of cutting edge developments in the field. Featuring a wonderful balance of presentations from academia, government and industry, the role of cytokines in health and disease…
Dear Colleague,GTC's 11th Cytokines and Inflammation Conference, one of four parallel tracks of the Novel Immunotherapeutics Summit on January 31 - February 1, 2013 in San Diego, CA, promotes a dynamic exchange of cutting edge developments in the field. Featuring a wonderful balance of presentations from academia, government and industry, the role of cytokines in health and disease…
31.01.2013
Immunogenicity & Immunotoxicity
Dear Colleague, GTC is proud to announce its inaugural Immunogenicity and Immunotoxicity Conference, one of four parallel tracks to the 2nd Novel Immunotherapeutics Summit on January 31 - February 1, 2013 San Diego, CA. This is the West Coast's first 2 day conference that brings together leading experts in industry, academia and the FDA. The inaugural conference will cover important…
Dear Colleague, GTC is proud to announce its inaugural Immunogenicity and Immunotoxicity Conference, one of four parallel tracks to the 2nd Novel Immunotherapeutics Summit on January 31 - February 1, 2013 San Diego, CA. This is the West Coast's first 2 day conference that brings together leading experts in industry, academia and the FDA. The inaugural conference will cover important…
31.01.2013
5th Immunotherapeutics & Immunomonitoring Conference
Dear Colleague,Ron Levy, Professor of Medicine & Chief, Division of Oncology at Stanford University will give the Keynote Presentation on "Antibody Therapy of Cancer: Targeting the Cancer Cell and Targeting the Immune System" at the 5th Immunotherapeutics & Immunomonitoring Conference to be held on Jan 31 - Feb 1, 2013 in San Diego, CA. Monoclonal antibodies can be…
Dear Colleague,Ron Levy, Professor of Medicine & Chief, Division of Oncology at Stanford University will give the Keynote Presentation on "Antibody Therapy of Cancer: Targeting the Cancer Cell and Targeting the Immune System" at the 5th Immunotherapeutics & Immunomonitoring Conference to be held on Jan 31 - Feb 1, 2013 in San Diego, CA. Monoclonal antibodies can be…
30.01.2013
2nd Novel Immunotherapeutics Summit
Dear Colleague,The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity,…
Dear Colleague,The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 - Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity,…
30.01.2013
Immune Responses in Tumor Microenvironment Workshop
Dear Colleague, GTC is proud to present the Immune Responses in Tumor Microenvironment Workshop to be held on Jan 30, 2013 in San Diego, CA. This is a half day workshop and also part of the 2nd Novel Immunotherapeutic Summit.This workshop is intended for researchers and scientists conducting preclinical or clinical studies in the field of tumor immunology, interested in the role of…
Dear Colleague, GTC is proud to present the Immune Responses in Tumor Microenvironment Workshop to be held on Jan 30, 2013 in San Diego, CA. This is a half day workshop and also part of the 2nd Novel Immunotherapeutic Summit.This workshop is intended for researchers and scientists conducting preclinical or clinical studies in the field of tumor immunology, interested in the role of…